Zogenix (ZGNX) Gets FDA Approval of Zohydro ER

Zogenix, Inc. (Nasdaq:ZGNX), announced that the FDA has approved a new formulation of Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek™. BeadTek is a formulation technology designed to provide abuse-deterrent properties without changing the release properties of hydrocodone when Zohydro ER is used as intended. Concurrently, Zogenix has ongoing Human Abuse Liability studies, which […] View the full post at: Zogenix (ZGNX) Gets FDA Approval of Zohydro ER No related posts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.